Your Unread Messages in Pharmacy
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
ASA as effective as sumatriptan in treatment of acute migraines
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Pain Managers and Prescribers
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
841 Effect of loading dose and formulation on safety and efficacy of conivaptan in treatment of euvolemic and hypervolemic hyponatremia American Journal of Health-System Pharmacy, March 28, 2011
842 Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer Cancer, March 28, 2011 Clinical Article
843 Effects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin American Journal of Health-System Pharmacy, March 28, 2011
844 The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene British Journal of Clinical Pharmacology, March 24, 2011
845 High-Dose Ketorolac Affects Adult Spinal Fusion: A Meta-Analysis of the Effect of Perioperative Nonsteroidal Anti-Inflammatory Drugs on Spinal Fusion Spine, March 24, 2011 Evidence Based Medicine Clinical Article
846 Analysis of efficacy and cost-effectiveness of high-dose arabinoside versus daunorubicin chemotherapy in older adult patients with acute myeloid leukemia by cytogenetic risk profile: retrospective review from China International Journal of Hematology, March 24, 2011
847 Mechanisms of fingolimods efficacy and adverse effects in multiple sclerosis Annals of Neurology , March 22, 2011 Clinical Article
848 Prevention of peptic ulcers with esomeprazole in patients at risk for ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON) Heart, March 22, 2011 Clinical Article
849 Role of Omeprazole Dosage and Cytochrome P450 2C19 Genotype in Patients Receiving Omeprazole-Amoxicillin Dual Therapy for Helicobacter pylori Eradication Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 18, 2011
850 Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention: The GRAVITAS Randomized Trial Full Text JAMA, March 17, 2011 Clinical Article
851 Optimizing initial vancomycin dosing in burn patients Burns, March 16, 2011 Clinical Article
852 Low-Dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease Clinical Gastroenterology and Hepatology , March 16, 2011 Clinical Article
853 Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barretts oesophagus for 1 year Alimentary Pharmacology and Therapeutics, March 14, 2011 Clinical Article
854 Pediatric Dosing Errors Quite Common Full Text U.S. Pharmacist, March 14, 2011
855 Agreement between equations estimating glomerular filtration rate in elderly nursing home residents and in hospitalised patients: implications for drug dosing Age and Aging, March 14, 2011
856 Paliperidone extended-release: does it have a place in antipsychotic therapy Full Text Drug Design, Development and Therapy, March 14, 2011
857 A Large Observational Study of Cardiovascular Outcomes Associated With Atorvastatin or Simvastatin Therapy in Hypertensive Patients Without Prior Cardiovascular Disease American Journal of Therapeutics, March 11, 2011 Clinical Article
858 Urinary Pharmacokinetics and Bactericidal Activity of Finafloxacin (200 and 800 mg) in Healthy Volunteers Receiving a Single Oral Dose Chemotherapy, March 11, 2011
859 Pharmacokinetics of the mono-hydroxy derivative of oxcarbazepine and its enantiomers after a single i.v. dose given as racemate compared with a single oral dose of oxcarbazepine Drug Metabolism and Disposition, March 10, 2011
860 Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers The Journal of Clinical Pharmacology, March 10, 2011
1 Once-Weekly Exenatide: An Extended-Duration Glucagon-Like Peptide Agonist for the Treatment of Type 2 Diabetes Mellitus Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 3, 2013
2
Understanding the dose-response relationship of allopurinol: predicting the optimal dosage
British Journal of Clinical Pharmacology, April 19, 2013
Exclusive Author Commentary
3 The danger with cutting medication patches American Pharmacists Association News, March 15, 2013 Free full text
4 Gentamicin Pharmacokinetics and Dosing in Neonates with Hypoxic Ischemic Encephalopathy Receiving Hypothermia Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 2, 2013
5 Risk of Asthma Exacerbation, Asthma-Related Health Care Utilization and Costs, and Adherence to Controller Therapy in Patients with Asthma Receiving Fluticasone Propionate/Salmeterol Inhalation Powder 100µg/50µg Versus Mometasone Furoate Inhalation Powder Journal of Asthma, March 19, 2013
6 Risk Factors for a Low Linezolid Trough Plasma Concentration in Acute Infections Antimicrobial Agents and Chemotherapy, March 29, 2013 Review Article
7 Opioid Overdose: What Hospital Pharmacists Should Know U.S. Pharmacist, April 26, 2013 Free full text
8 High-dose FOLFIRI, Surgery, and Radiofrequency Ablation for Patients with Unresectable Liver Metastases from Colorectal Cancer Anticancer Research, April 9, 2013
9 Towards more reliable automated multi-dose dispensing: retrospective follow-up study on medication dose errors and product defects Drug Development and Industrial Pharmacy, March 26, 2013 Review Article
10 Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer Breast Cancer Research and Treatment, April 17, 2013
11 Efficacy of high doses of oral penicillin versus amoxicillin in the treatment of adults with non-severe pneumonia attended in the community: study protocol for a randomised controlled trial BMC Family Practice, April 18, 2013 Free full text
12 Validation of a Novel Approach for Dose Individualization in Pharmacotherapy Using Gabapentin in a Proof of Principles Study Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 8, 2013
13 Software for Dosage Individualization of Voriconazole for Immunocompromised Patients Antimicrobial Agents and Chemotherapy, March 25, 2013
14 Creative solutions to extraordinary challenges in clinical trials: methodology of a phase III trial of azithromycin and chloroquine fixed-dose combination in pregnant women in Africa Malaria Journal, April 16, 2013 Free full text Review Article
15 Efficacy and tolerability of 5-day azacytidine dose-intensified regimen in higher-risk MDS Annals of Hematology, April 22, 2013
16 Citalopram and cardiac toxicity European Journal of Clinical Pharmacology, April 18, 2013 Review Article
17 Dynamic View on Affordability of Fixed-Dose Combination Antihypertensive Drug Therapy American Journal of Hypertension, April 3, 2013
18 Methadone at tapered doses for the management of opioid withdrawal Cochrane Reviews, March 6, 2013 Review Article
19 Efficacy and Plasma Drug Concentrations With Nondaily Dosing of Rosuvastatin Canadian Journal of Cardiology, March 13, 2013
20 Cotrimoxazole plasma levels, dialyzer clearance and total removal by extended dialysis in a patient with acute kidney injury: risk of under-dosing using current dosing recommendations BMC Pharmacology & Toxicology, April 15, 2013 Free full text
Indexed Journals in Pharmacy: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close